1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Industry in the United Kingdom Market Research & Statistics

Therapy Industry in the United Kingdom Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 200 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Industry in the UK

  • April 2015
    16 pages
  • Cancer  

  • United Kingdom  

View report >

Therapy Industry in the UK

  • February 2015
    13 pages
  • Therapy  

  • United Kingdom  

View report >

Therapy Industry

  • January 2015
    14 pages
  • Therapy  

  • Canada  

    United Kingdom  

    United States  

View report >

The future of the Therapy Industry in the UK

  • January 2014
    5 pages
  • Therapy  

  • United Kingdom  

View report >

The future of the Therapy Industry in the US and the UK

  • September 2013
    30 pages
  • Therapy  

    Oncology  

    Cardiology  

  • United States  

    United Kingdom  

    Europe  

View report >

Therapy Industry in the UK

  • January 2013
    30 pages
  • Therapy  

    Mental Health  

    Mental Illness  

  • United Kingdom  

View report >

Oncology Industry in the UK

  • February 2015
    139 pages
  • Oncology  

    Prostate Cancer  

    Cancer  

  • United Kingdom  

    Europe  

View report >

Drug Industry in the UK

  • February 2015
    123 pages
  • Drug  

    Cardiology  

    Heart Failure  

  • United Kingdom  

View report >

Pathology Description in the UK

  • February 2015
    13 pages
  • Cancer  

    Oncology  

    Chemotherapy  

  • United Kingdom  

View report >

Oncology Industry in the UK

  • February 2015
    24 pages
  • Oncology  

    Cancer Therapy  

  • United Kingdom  

View report >


26 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 695)

Physician Views: Oncologist expectations for immunotherapy in first-line non-small-cell lung cancer

Physician Views: Oncologist expectations for immunotherapy in first-line non-small-cell lung cancer

  • $ 695
  • Industry report
  • June 2015
  • by Firstword Pharma

Much of the debate around cancer immunotherapy at the recent ASCO annual meeting focused on the commercial positioning of a new class of product – the PD-1/PD-L1 inhibitors – in second-line, non-small-cell ...

Atopix Therapeutics Limited - Pharmaceuticals & Healthc ...

May 2015 $ 250

Ensemble Discovery Corporation - Pharmaceuticals & Heal ...

April 2015 $ 250

Pulmagen Therapeutics Llp - Pharmaceuticals & Healthcar ...

March 2015 $ 250

Epicast Report: Duchenne Muscular Dystrophy - Epidemiol ...

March 2015 $ 3 995

Immatics Biotechnologies Gmbh - Product Pipeline Review ...

February 2015 $ 1 500

Adc Therapeutics Sarl - Product Pipeline Review - 2015

February 2015 $ 1 500

Osteonecrosis - Pipeline Review, H2 2014

December 2014 $ 2 000

Physician Views: Reaction To Bristol-myers Squibb%s Opd ...

November 2014 $ 681

United Kingdom Wound Care Management Market Outlook To ...

October 2014 $ 9 995

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.